Patrick Janulis1, Barrett W Montgomery2, James C Anthony2. 1. Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, 625 N Michigan Ave, Chicago, IL 60611, United States. Electronic address: patrick.janulis@northwestern.edu. 2. Department of Epidemiology and Biostatistics, College of Human Medicine, Michigan State University, B601 West Fee Hall, 909 Wilson Road, East Lansing, MI 48824-1030, United States.
Abstract
BACKGROUND: Many people who inject drugs (PWID) lack access to a new sterile syringe each time they inject, with increased risk of injection-related harms, including spread of communicable diseases. In the United States (US), restricted access is largely due to state laws and policies regulating syringe access. Our aim in this US-focused study is to estimate variations in syringe acquisition behavior in relation to state-level syringe sale policies, drawing upon self-identified PWID in a nationally representative sample survey. METHODS: Estimates were obtained on the source of the last used syringe from participants of the National Survey on Drug Use and Health (NSDUH) years 2002-2011. States were classified as having restricted syringe policies if they had any restriction on the sale of syringes during the study period (e.g., required a prescription or limited the number being sold). RESULTS: In states with unrestricted syringe sale policies, PWID were more likely to have obtained their most recently used syringe from a safe source (Difference (%) = 9.8, 95% CI: 1.9, 17.7). This difference was largely driven by a larger percent of injectors obtaining syringes from a pharmacy in unrestricted states (Difference = 20.4, 95% CI: 12.2, 28.6) but was partially offset by fewer injectors obtaining syringes from syringe exchange programs (Difference = -10.7, 95% CI: -16.1, -5.3). CONCLUSION: These new findings, taken with other evidence, should help promote removal of policy barriers that now thwart syringe acquisition from a safe source. We hope this additional evidence will provoke policy discussions and may influence regulations that promote public health and reduce the spread of communicable diseases.
BACKGROUND: Many people who inject drugs (PWID) lack access to a new sterile syringe each time they inject, with increased risk of injection-related harms, including spread of communicable diseases. In the United States (US), restricted access is largely due to state laws and policies regulating syringe access. Our aim in this US-focused study is to estimate variations in syringe acquisition behavior in relation to state-level syringe sale policies, drawing upon self-identified PWID in a nationally representative sample survey. METHODS: Estimates were obtained on the source of the last used syringe from participants of the National Survey on Drug Use and Health (NSDUH) years 2002-2011. States were classified as having restricted syringe policies if they had any restriction on the sale of syringes during the study period (e.g., required a prescription or limited the number being sold). RESULTS: In states with unrestricted syringe sale policies, PWID were more likely to have obtained their most recently used syringe from a safe source (Difference (%) = 9.8, 95% CI: 1.9, 17.7). This difference was largely driven by a larger percent of injectors obtaining syringes from a pharmacy in unrestricted states (Difference = 20.4, 95% CI: 12.2, 28.6) but was partially offset by fewer injectors obtaining syringes from syringe exchange programs (Difference = -10.7, 95% CI: -16.1, -5.3). CONCLUSION: These new findings, taken with other evidence, should help promote removal of policy barriers that now thwart syringe acquisition from a safe source. We hope this additional evidence will provoke policy discussions and may influence regulations that promote public health and reduce the spread of communicable diseases.
Authors: Ryan J Deibert; Gary Goldbaum; Theodore R Parker; Holly Hagan; Robert Marks; Michael Hanrahan; Hanne Thiede Journal: Am J Public Health Date: 2006-06-29 Impact factor: 9.308
Authors: Josiah D Rich; Joseph W Hogan; Francis Wolf; Allison DeLong; Nickolas D Zaller; Meenakshi Mehrotra; Steven Reinert Journal: Drug Alcohol Depend Date: 2007-03-26 Impact factor: 4.492
Authors: Abby E Rudolph; Natalie D Crawford; Danielle C Ompad; Ebele O Benjamin; Rachel J Stern; Crystal M Fuller Journal: J Am Pharm Assoc (2003) Date: 2010 Mar-Apr 1
Authors: Saira S Siddiqui; Richard F Armenta; Jennifer L Evans; Michelle Yu; Jazmine Cuevas-Mota; Kimberly Page; Peter Davidson; Richard S Garfein Journal: Int J Drug Policy Date: 2015-06-24